The neuropathological basis to the functional role of microglia/macrophages in gliomas

Davide Schiffer1, Marta Mellai2, Enrica Bovio2

  • 1Research Center, Policlinico di Monza Foundation, Via Pietro Micca 29, 13100, Vercelli, Italy. davide.schiffer@unito.it.

Insights

Microglia/macrophages in brain tumors (gliomas) may promote cancer growth by suppressing the immune system. However, only CD163-positive cells show a link to patient survival, not the total microglia count.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cell Biology

Background:

  • Microglia/macrophages are key immune cells in the central nervous system (CNS).
  • Their role in non-neoplastic CNS conditions differs from their function in brain tumors (gliomas).
  • Recent research focuses on the dual role of these cells in glioma progression.

Purpose of the Study:

  • To review recent findings on microglia/macrophage function and significance in gliomas.
  • To investigate the impact of microglia on tumor proliferation and immunosuppression.
  • To explore the prognostic value of different microglia phenotypes in glioma patients.

Main Methods:

  • In vitro cell cultures.
  • Animal tumor transplant models.
  • Immunohistochemistry to identify microglia phenotypes (e.g., ramified, macrophagic).

Main Results:

  • Most studies suggest microglia/macrophages favor glioma proliferation via immunosuppression induced by tumor cells.
  • Different microglia phenotypes are observed in gliomas.
  • A significant inverse correlation was found between CD163-positive microglia/macrophages and glioma patient survival.
  • Total microglia numbers did not correlate with glioma malignancy grade.

Conclusions:

  • Microglia/macrophages play a complex role in gliomas, often promoting tumor growth.
  • The functional relevance of microglia phenotypes observed in experimental models to human glioma pathology requires further investigation.
  • CD163-positive microglia/macrophages are potential prognostic biomarkers in glioma patients.